HRP20181352T1 - Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu - Google Patents

Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu

Info

Publication number
HRP20181352T1
HRP20181352T1 HRP20181352TT HRP20181352T HRP20181352T1 HR P20181352 T1 HRP20181352 T1 HR P20181352T1 HR P20181352T T HRP20181352T T HR P20181352TT HR P20181352 T HRP20181352 T HR P20181352T HR P20181352 T1 HRP20181352 T1 HR P20181352T1
Authority
HR
Croatia
Prior art keywords
tissue
reagents
cancer
procedures
maintenance
Prior art date
Application number
HRP20181352TT
Other languages
English (en)
Croatian (hr)
Inventor
Tony K. Baker
Original Assignee
Truckee Applied Genomics, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truckee Applied Genomics, Llc filed Critical Truckee Applied Genomics, Llc
Publication of HRP20181352T1 publication Critical patent/HRP20181352T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Physiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HRP20181352TT 2013-03-15 2014-03-14 Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu HRP20181352T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798627P 2013-03-15 2013-03-15
EP14763797.9A EP2970878B1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue
PCT/US2014/029198 WO2014144682A1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue

Publications (1)

Publication Number Publication Date
HRP20181352T1 true HRP20181352T1 (hr) 2018-12-14

Family

ID=51528685

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181352TT HRP20181352T1 (hr) 2013-03-15 2014-03-14 Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu

Country Status (17)

Country Link
US (5) US9113623B2 (https=)
EP (2) EP3581643A1 (https=)
JP (1) JP6465857B2 (https=)
CN (2) CN105121629B (https=)
CA (1) CA2941929C (https=)
CY (1) CY1120801T1 (https=)
DK (1) DK2970878T3 (https=)
ES (1) ES2684582T3 (https=)
HR (1) HRP20181352T1 (https=)
HU (1) HUE039933T2 (https=)
LT (1) LT2970878T (https=)
PL (1) PL2970878T3 (https=)
PT (1) PT2970878T (https=)
RS (1) RS57900B1 (https=)
SI (1) SI2970878T1 (https=)
SM (1) SMT201800457T1 (https=)
WO (1) WO2014144682A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2684582T3 (es) 2013-03-15 2018-10-03 Truckee Applied Genomics, Llc Métodos y reactivos para mantener la viabilidad de células cancerosas en tejido eliminado quirúrgicamente
CN107002063A (zh) 2014-11-25 2017-08-01 生物辐射实验室股份有限公司 精氨酸提高聚合酶储存稳定性
CN107333750A (zh) * 2017-06-11 2017-11-10 成都吱吖科技有限公司 一种长时血液细胞稳定剂
EP4089180B1 (en) 2019-09-17 2025-06-25 Longhorn Vaccines and Diagnostics, LLC Multipurpose compositions for collecting and transporting biological material
WO2022010916A1 (en) * 2020-07-07 2022-01-13 Truckee Applied Genomics, Llc Cell preservation reagents and methods of use
CN117063915B (zh) * 2023-08-17 2026-02-24 镜像绮点(上海)细胞技术有限公司 原代肿瘤细胞冻存液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409826A (en) * 1993-06-08 1995-04-25 Coulter Corporation Preserved, non-infectious control cells prepared by the modulation or modification of normal cells
JP2000509018A (ja) * 1996-03-26 2000-07-18 イーライ・リリー・アンド・カンパニー 肥満タンパク質製剤
US20010007673A1 (en) 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
US20080064108A1 (en) 1997-12-10 2008-03-13 Tony Baker Urine Preservation System
WO1999029904A2 (en) 1997-12-10 1999-06-17 Sierra Diagnostics, Inc. Methods and reagents for preservation of dna in bodily fluids
WO2002046368A1 (fr) * 2000-12-04 2002-06-13 Humantec Ltd. Liquide de conservation de cellules et procede de conservation de cellules dans lequel ledit liquide est utilise
KR20020066778A (ko) 2001-02-13 2002-08-21 한국과학기술연구원 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법
WO2008111981A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation of macromolecules
AU2003300899A1 (en) * 2002-12-12 2004-06-30 Oncotech, Inc. Genes related to sensitivity and resistance to chemotherapeutic drug treatment
US8793895B2 (en) * 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
CN101617045A (zh) 2006-09-12 2009-12-30 谢拉分子公司 使用离液剂的缓冲溶液去除核酸的分子分析干扰物
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
JP2010508090A (ja) 2006-10-27 2010-03-18 シエラ モレキュラー コーポレイション 貫通可能な隔壁キャップ
ES2394815T3 (es) 2006-12-13 2013-02-05 F. Hoffmann-La Roche Ag Utilización de TDE para el aislamiento de ácidos nucleicos
AU2008224883A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule
KR20100102607A (ko) * 2007-11-12 2010-09-24 바이파 사이언스 인코포레이티드 Parp 억제제를 단독으로 사용하거나 항종양제와 병용하여 자궁암 및 난소암을 치료하는 방법
US20100003748A1 (en) * 2008-07-03 2010-01-07 Tony Baker Compositions, systems, and methods for stabilization of a cell and/or macromolecule
WO2010028156A2 (en) 2008-09-04 2010-03-11 Board Of Regents, The University Of Texas System Dual modality detection of apoptosis
US9133343B2 (en) 2009-11-30 2015-09-15 Enzo Biochem, Inc. Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
CN102318597B (zh) * 2011-08-19 2013-04-03 张雪云 一种液基细胞保存液组合物及其制备方法
ES2684582T3 (es) 2013-03-15 2018-10-03 Truckee Applied Genomics, Llc Métodos y reactivos para mantener la viabilidad de células cancerosas en tejido eliminado quirúrgicamente

Also Published As

Publication number Publication date
SMT201800457T1 (it) 2018-11-09
DK2970878T3 (en) 2018-09-03
US20140272921A1 (en) 2014-09-18
US10772318B2 (en) 2020-09-15
PL2970878T3 (pl) 2019-01-31
EP2970878A4 (en) 2016-08-03
CN112806352A (zh) 2021-05-18
US9565852B2 (en) 2017-02-14
EP2970878A1 (en) 2016-01-20
WO2014144682A4 (en) 2014-12-24
CY1120801T1 (el) 2019-12-11
CA2941929A1 (en) 2014-09-18
WO2014144682A1 (en) 2014-09-18
JP2016512693A (ja) 2016-05-09
ES2684582T3 (es) 2018-10-03
US9113623B2 (en) 2015-08-25
US9445586B2 (en) 2016-09-20
WO2014144682A8 (en) 2015-08-13
US20170215410A1 (en) 2017-08-03
US20150327539A1 (en) 2015-11-19
JP6465857B2 (ja) 2019-02-06
CA2941929C (en) 2021-02-23
CN105121629B (zh) 2020-12-18
LT2970878T (lt) 2018-11-12
SI2970878T1 (sl) 2019-02-28
RS57900B1 (sr) 2019-01-31
CN105121629A (zh) 2015-12-02
PT2970878T (pt) 2018-10-09
US9949474B2 (en) 2018-04-24
EP3581643A1 (en) 2019-12-18
US20150230454A1 (en) 2015-08-20
HUE039933T2 (hu) 2019-02-28
EP2970878B1 (en) 2018-05-23
US20160235055A1 (en) 2016-08-18
HK1220481A1 (en) 2017-05-05

Similar Documents

Publication Publication Date Title
IL246141A0 (en) Methods for adhering tissue surfaces and materials and biomedical uses thereof
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
ME02911B (me) Derivati c17 heteroarila oleanolinske kisjeline i postupci za njihovu upotrebu
HRP20260139T1 (hr) Farmaceutski pripravak, postupci za liječenje i njegove uporabe
IL239007B (en) Eribulin for use in the treatment of breast cancer
IL245337B (en) Combinations of checkpoint inhibitors and therapeutics to treat cancer
HRP20181994T1 (hr) Neuroaktivni steroidi i postupci za njihovu upotrebu
HRP20181302T1 (hr) Terapija za obnavljanje mikrobiota (mrt), pripravci i postupci proizvodnje
BR112015028115A2 (pt) métodos e composições para o tratamento de câncer
SI2981822T1 (sl) Sestavki in postopki za modulacijo rastnega dejavnika
IL243408A0 (en) Diagnosis and therapy of cancer involving cancer stem cells
IL242394B (en) Cenicriviroc compositions and methods of making and using the same
HRP20180126T1 (hr) Pripravci pcsk9 irna i postupci njihove upotrebe
PL3489261T3 (pl) Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
HRP20170840T1 (hr) Supstituirani ksantini i metode njihove uporabe
HRP20171365T1 (hr) Terapeutske polimerne nanočestice i postupci dobivanja i njihovog korištenja
IL239453A0 (en) Preparations and methods for treating cancer using bacteria
EP2958936A4 (en) METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE
DE112013005641A5 (de) Vorrichtung zur insbesondere transperinealen Untersuchung von Patienten
HRP20182138T1 (hr) Modificirani serpini za liječenje poremećaja s krvarenjem
PL3200815T3 (pl) Sposoby i kompozycje do leczenia nowotworu
EP2958571C0 (en) DNA HYPOMETHYLING AGENTS FOR CANCER THERAPY
HRP20180729T1 (hr) Derivati sulfonil piperidina i njihova uporaba za liječenje bolesti posredovanih prokinetikinom
IL246269B (en) Compositions and methods for treating fatty tissue buildup
EP2967653A4 (en) METHOD AND TECHNIQUES FOR SPINE SURGERY